Agilent Technologies, Inc. $A Shares Sold by Generali Asset Management SPA SGR

Key Points

• Generali Asset Management SPA SGR reduced its stake in Agilent Technologies by 25.9%, selling 14,422 shares and owning a total of 41,368 shares valued at approximately $4.88 million.
• Agilent Technologies reported $1.37 earnings per share for the last quarter, meeting analysts' expectations, and had revenue of $1.74 billion, exceeding estimates of $1.67 billion.
• The company announced a quarterly dividend of $0.248 per share, resulting in an annualized dividend yield of 0.7%.

Generali Asset Management SPA SGR lessened its stake in Agilent Technologies, Inc. (NYSE:A - Free Report) by 25.9% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 41,368 shares of the medical research company's stock after selling 14,422 shares during the period. Generali Asset Management SPA SGR's holdings in Agilent Technologies were worth $4,882,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently bought and sold shares of the stock. Vanguard Group Inc. boosted its stake in Agilent Technologies by 0.7% in the first quarter. Vanguard Group Inc. now owns 33,408,626 shares of the medical research company's stock valued at $3,908,141,000 after acquiring an additional 240,965 shares in the last quarter. Pictet Asset Management Holding SA boosted its stake in Agilent Technologies by 2.5% in the first quarter. Pictet Asset Management Holding SA now owns 5,341,870 shares of the medical research company's stock valued at $624,888,000 after acquiring an additional 128,131 shares in the last quarter. Generation Investment Management LLP boosted its stake in Agilent Technologies by 19.8% in the first quarter. Generation Investment Management LLP now owns 4,983,556 shares of the medical research company's stock valued at $582,976,000 after acquiring an additional 824,243 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in shares of Agilent Technologies by 18.7% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,836,105 shares of the medical research company's stock worth $448,748,000 after buying an additional 604,124 shares during the period. Finally, Impax Asset Management Group plc boosted its stake in shares of Agilent Technologies by 3.6% during the first quarter. Impax Asset Management Group plc now owns 2,931,794 shares of the medical research company's stock worth $342,961,000 after buying an additional 102,365 shares during the period.

Agilent Technologies Trading Up 0.8%

Shares of Agilent Technologies stock opened at $139.14 on Thursday. Agilent Technologies, Inc. has a 12-month low of $96.43 and a 12-month high of $153.84. The company has a current ratio of 2.25, a quick ratio of 1.71 and a debt-to-equity ratio of 0.53. The stock has a market cap of $39.45 billion, a PE ratio of 32.66, a price-to-earnings-growth ratio of 4.51 and a beta of 1.26. The company has a 50-day moving average of $126.49 and a two-hundred day moving average of $117.46.

Agilent Technologies (NYSE:A - Get Free Report) last issued its earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $1.37. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The company had revenue of $1.74 billion during the quarter, compared to analysts' expectations of $1.67 billion. During the same period last year, the company posted $1.32 earnings per share. The firm's quarterly revenue was up 10.1% compared to the same quarter last year. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. On average, research analysts anticipate that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 22nd. Stockholders of record on Tuesday, September 30th will be paid a dividend of $0.248 per share. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend is Tuesday, September 30th. Agilent Technologies's dividend payout ratio (DPR) is 23.24%.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on A. Weiss Ratings reiterated a "hold (c)" rating on shares of Agilent Technologies in a research note on Wednesday, October 8th. Rothschild & Co Redburn began coverage on shares of Agilent Technologies in a research note on Wednesday, October 8th. They set a "buy" rating and a $165.00 target price for the company. Barclays increased their target price on shares of Agilent Technologies from $125.00 to $150.00 and gave the stock an "equal weight" rating in a research note on Thursday, October 2nd. Wall Street Zen upgraded shares of Agilent Technologies from a "hold" rating to a "buy" rating in a research note on Friday, October 3rd. Finally, Evercore ISI increased their target price on shares of Agilent Technologies from $128.00 to $140.00 and gave the stock an "in-line" rating in a research note on Tuesday, October 7th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $149.62.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.